$ANIK (Anika Therapeutics Inc)

$ANIK {{ '2016-02-25T16:55:15+0000' | timeago}} • Announcement

$ANIK said that it will enter into an accelerated share repurchase (ASR) program to repurchase $25MM of its outstanding common stock. The company plans to utilize existing cash on hand to fund the ASR program. $ANIK expects the ASR program to commence in late Feb. 2016 and to be completed in 3Q16.

$SYK {{ '2018-01-09T17:21:37+0000' | timeago}} • Announcement

$SYK said that for 4Q17 its preliminary results are of net sales growth of 10% to $3.5Bil, while for FY17, its net sales grew 9.9% to $12.4Bil. Excluding the impact of foreign currency & acquisitions, net sales rose 8.1% and 7.1% in 4Q17 and FY17. For 2018, $SYK expects modest headwinds that will be manageable within its overall financial targets.

$HRC {{ '2018-01-09T17:07:14+0000' | timeago}} • Announcement

$HRC announced its preliminary 1Q18 revenue. For this period, the company expects worldwide revenue of approx $670MM, an increase of 5% YoY. Core revenue increased approx 2%, exceeding the company's previously issued guidance of flat core revenue growth.

$TFX {{ '2018-01-02T14:56:01+0000' | timeago}} • Announcement

$TFX completed its senior leadership transition. Effective Jan. 1, 2018, Liam Kelly, who was previously President & COO, assumed the position of President & CEO. Mr. Kelly succeeds Benson Smith, who retired as CEO, effective Dec. 31, 2017. Mr. Smith will continue to serve as non-executive Chairman of the Board.

$ANIK {{ '2017-12-27T17:14:26+0000' | timeago}} • Announcement

Orthopedic medicines company $ANIK said that its HA-based bone void filler has received 510(k) clearance from the U.S. Food and Drug Administration. Anika's bone repair treatment is an injectable, HA-based, settable osteoconductive calcium phosphate bone graft substitute material indicated for filling bone voids of the skeletal system.

$TFX {{ '2017-12-12T15:30:39+0000' | timeago}} • Announcement

$TFX's respiratory division has signed a new group purchasing agreement with HealthTrust. The Respiratory Heaters & Accessories agreement which became effective Dec. 1, 2017, covers Teleflex's full line of Active Humidification, Non Invasive Ventilation (NIV), and High Flow Nasal Cannula Therapy (HFNCT) products.

$SYK {{ '2017-12-12T14:28:46+0000' | timeago}} • Announcement

$SYK said Howard Cox Jr. has notified the company that he will not stand for re-election at Stryker's 2018 Annual Meeting, which is expected to be held on May 2, 2018. In light of Cox's immense contributions to the company, he will be named Director Emeritus.

$HLS {{ '2017-12-12T13:23:46+0000' | timeago}} • Announcement

$HLS appointed Nancy Schlichting as an independent director, effective Dec. 11, 2017. With this appointment, the Board will expand to 11 directors. Schlichting currently serves on the boards of $WBA and $HRC.

$SYK {{ '2017-12-11T21:53:53+0000' | timeago}} • Announcement

$SYK said that the simplified public tender offer for the shares and BSAAR warrants of VEXIM has closed. $SYK, which already owned over 50% of the share capital and voting rights of VEXIM, acquired an additional 4.04MM shares during the offer period, as well as 226,520 BSAAR warrants that it has exercised for new shares of VEXIM.

$ENTL {{ '2017-12-08T17:39:22+0000' | timeago}} • Announcement

Rowley Law PLLC is investigating potential claims against $ENTL and its BoD for breach of fiduciary duty concerning the proposed acquisition of the company by $SYK. Stockholders will receive $24.00 in cash for each share of $ENTL that they hold. The transaction is valued at about $662MM.

$SYK {{ '2017-12-07T16:33:56+0000' | timeago}} • Announcement

$SYK agreed to buy $ENTL for $24 per share, or an equity value of about $662MM. The transaction is expected to be dilutive to $SYK's 2018 adjusted EPS by about $0.04 and accretive thereafter. Guggenheim Securities served as financial advisor and Skadden, Arps, Slate, Meagher & Flom LLP served as outside legal counsel for $SYK.

$SYK {{ '2017-12-07T14:25:00+0000' | timeago}} • Announcement

$SYK BoD declared a quarterly dividend of $0.47 per share payable on January 31, 2018 to shareholders of record on December 29, 2017. This  represents an increase of approx. 11% compared to the prior year and the previous quarter.

$GMED {{ '2017-12-01T13:40:37+0000' | timeago}} • Announcement

$GMED, a musculoskeletal solutions company, reported positive results from its 7-year clinical trial on SECURE-C Cervical Artificial Disc in the treatment of cervical disc disease. SECURE-C, which is designed for disc reconstruction and motion preservation at the operated disc level, showed superior success rate compared to conventional therapies.

$HRC {{ '2017-11-27T15:52:09+0000' | timeago}} • Announcement

IMRIS and $HRC said Hill-Rom's Trumpf Medical has completed device listing and registration with FDA for a new multi-functional operating room table specifically designed for the IMRIS Surgical Theatre. Full market launch is expected in early 2018.

$RMD {{ '2017-11-17T16:34:01+0000' | timeago}} • Announcement

$RMD elected accomplished healthcare executive Karen Drexler to its BoD. Also, Chris Roberts is retiring after serving on $RMD's Board for more than 25 years. Drexler's appointment and Roberts' retirement both took effect following the company's annual meeting of shareholders held Nov. 16.

$RMD {{ '2017-11-13T19:41:35+0000' | timeago}} • Infographic

$RMD ResMed Inc Earnings AlphaGraphic: Q1 2018 Highlights

$SYK {{ '2017-10-27T11:50:44+0000' | timeago}} • Infographic

$SYK Stryker Corp. Earnings AlphaGraphic: Q3 2017 Highlights

$ISRG {{ '2017-10-19T21:40:26+0000' | timeago}} • Announcement

Worldwide da Vinci procedures grew approx. 15% in 3Q17 as $ISRG shipped 169 da Vinci Surgical Systems during the quarter. With $TRXC already in its sight, Intuitive Surgical will also be eyeing $MDT with much more concern as Medtronic is set to roll out its surgical robot system next year.

$ISRG {{ '2017-10-19T21:22:14+0000' | timeago}} • Announcement

Amidst concern over an emerging competition for its da Vinci Surgical Systems, $ISRG posted its 3Q17 results where revenue increased 18% and profit grew 41%. Recently, the US FDA has shown the green light for $TRXC to market its Senhance Surgical Robotic System, the first system since 2010 to compete head-to-head against $ISRG's da Vinci system.

$HAE {{ '2017-10-18T15:38:09+0000' | timeago}} • Announcement

$HAE elected Robert Abernathy to its BoD. Abernathy has led major medical businesses in North America and Europe with Halyard Health, Inc. Abernathy served as Chairman of the Board and CEO of Halyard Health Inc., a $KMB spinoff medical technology company specializing in important patient health care needs.

$HAE {{ '2017-10-18T15:03:18+0000' | timeago}} • Announcement

$HAE elected Robert Abernathy to its BoD. Abernathy previously served on the Board of The Advanced Medical Technology Association (AdvaMed).

Recent Transcripts

ONVO (Organovo Holdings, Inc.)
Thursday, November 9 2017 - 10:00pm
TRXC (TransEnterix, Inc.)
Thursday, November 9 2017 - 9:30pm
GMED (Globus Medical, Inc.)
Wednesday, November 8 2017 - 10:30pm
STAA (STAAR Surgical Company)
Wednesday, November 8 2017 - 9:30pm
CCXI (ChemoCentryx, Inc.)
Tuesday, November 7 2017 - 10:00pm
HAE (Haemonetics Corporation)
Tuesday, November 7 2017 - 1:00pm
TXMD (TherapeuticsMD, Inc.)
Monday, November 6 2017 - 1:00pm
HRC (Hill-Rom Holdings, Inc.)
Friday, November 3 2017 - 12:00pm
IRIX (IRIDEX Corporation)
Thursday, November 2 2017 - 9:00pm
TFX (Teleflex Incorporated)
Thursday, November 2 2017 - 12:00pm
SYN (Synthetic Biologics Inc.)
Wednesday, November 1 2017 - 8:30pm
CRY (CryoLife Inc.)
Tuesday, October 31 2017 - 12:00pm
SYK (Stryker Corporation)
Thursday, October 26 2017 - 8:30pm
RMD (ResMed Inc.)
Thursday, October 26 2017 - 8:30pm
ANIK (Anika Therapeutics Inc)
Thursday, October 26 2017 - 1:00pm
PTN (Palatin Technologies Inc.)
Monday, September 25 2017 - 3:00pm
ONVO (Organovo Holdings, Inc.)
Wednesday, August 9 2017 - 9:00pm
CCXI (ChemoCentryx, Inc.)
Tuesday, August 8 2017 - 9:00pm
HAE (Haemonetics Corporation)
Monday, August 7 2017 - 12:00pm
IRIX (IRIDEX Corporation)
Thursday, August 3 2017 - 9:00pm

AlphaGraphics you may like